Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation

ABSTRACT:

SUBMITTER: Tang G 

PROVIDER: S-EPMC10561601 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature